Results 41 to 50 of about 12,689 (257)

Total cost, cases detected, incremental costs, incremental cases detected and incremental cost effectiveness ratio (ICER).

, 2015
Total cost, cases detected, incremental costs, incremental cases detected and incremental cost effectiveness ratio (ICER).
Richard E. Nelson (764526), Brian R. Jackson (233567), Edward R. Ashwood (764528), David G. Grenache (764527), Brandon S. Walker (764525), Robert L. Schmidt (764529)   +5 more
core   +1 more source

Cost-effectiveness analysis.

, 2023
Managing tibial fractures requires substantial health resources, which costs the health system. This study aimed to describe the costs of photobiomodulation (PBM) with LEDs in the healing process of soft tissue lesions associated with tibial fracture ...
Lara Jansiski Motta (8681628), Raquel Agnelli Mesquita-Ferrari (8681631), Kristianne Porta Santos Fernandes (8681625), Sandra Kalil Bussadori (8621904), Estela Capelas Barbosa (12248581), Frederico Carlos Jana Neto (17605045), Ana Luiza Cabrera Martimbianco (5454077), Fernanda Carolina Felix (17605051), Cinthya Cosme Gutierrez Duran (17605054), Diogo Valvano de Medeiros (17605048)   +9 more
core   +1 more source

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Details of incremental cost-effectiveness ratio computation.

, 2013
Details of incremental cost-effectiveness ratio computation.
Cristiana Pascutto (464517), Alessandra Pompa (464519), Roberta Ciampichini (464520), Alessandro Corso (464514), Lara Pochintesta (464521), Silvia Mangiacavalli (464515), Federica Cocito (464516), Lorenzo G. Mantovani (414007), Virginia Valeria Ferretti (464518)   +8 more
core   +1 more source

Cost-effectiveness acceptance curve (CEC).

, 2023
This study assessed the cost-effectiveness of different diabetic retinopathy (DR) screening strategies in rural regions in China by using a Markov model to make health economic evaluations.
Na Li (6550), Guanyan Li (13955389), Qingyue Gao (13955383), Shaofeng Hao (13955380), Ziyou Yuan (13955386), Shengfu Fan (13896345), Changyan Liu (9321797), Jianzhou Yang (4744092), Huilin Li (795365)   +8 more
core   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

BMC Health Services Research, 2019
Background Diabetic macular oedema (DMO) may lead to visual loss and blindness. Several pharmacological treatments are available on the National Health Service (NHS) to United Kingdom patients affected by this condition, including intravitreal vascular ...
Michal Pochopien, Annette Beiderbeck, Phil McEwan, Richard Zur, Mondher Toumi, Samuel Aballéa   +5 more
doaj   +1 more source

Cost, effectiveness and incremental cost-effectiveness ratio (vs. current scenario) by using PPSV–23 only.

, 2015
*ICER: incremental cost-effectiveness ratio (¥/QALY gained). All ICERs were rounded to the nearest thousand.Cost, effectiveness and incremental cost-effectiveness ratio (vs. current scenario) by using PPSV–23 only.
Masahide Kondo (636725), Ichiro Okubo (804142), Shu-ling Hoshi (804141)   +2 more
core   +1 more source

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel, Fauzia Hollangel, Caroline Packee, Amita Kapoor, Brad Rovin, Nathalie Costedoat‐Chalumeau, Shivani Garg   +6 more
wiley   +1 more source

Cost-effectiveness of physical activity-oriented interventions for improving mental health: a systematic review

BMC Public Health
Question Are physical activity-oriented interventions for improving mental health conditions cost-effective? This study systematically identified and summarized published evidence on the cost-effectiveness of physical activity-oriented interventions for ...
Noara Alhusseini, Tracy Kuo Lin, Kalin Werner, George Lin, Yasmin Altwaijri, Baian A. Baattaiah, Tim Bruckner, Reem AlAhmed, Abdulrahman Alkabbani, Reem F. Alsukait, Volkan Cetinkaya, Hazzaa M. Al-Hazzaa, Saleh A. Alqahtani   +12 more
doaj   +1 more source